Your workspace

Cases

AW

Amara Whitfield

Metastatic pancreatic adenocarcinoma

Meeting · 24 JulIn progress3 items outstanding

68% ready

DR

Daniel Rösch

Stage III melanoma, BRAF V600E

Meeting · 18 JulReady

Ready for meeting

PB

Priyanka Bose

Cholangiocarcinoma, FGFR2 fusion

Concluded · 14 JulRecommendation ready

Report drafted

MF

Marco Ferretti

Colorectal, MSI-high

Meeting · 2 AugEarly prepAwaiting team & data

30% ready

← All cases

Overview

Meet the Team

Preparation 3

Files 5

Research reports 1/2

Discussion

Meeting

Recommendation

68%

In progress

Three requirements are outstanding before this case is ready for the consortium meeting on 24 Jul.

RNA-seq raw overdueDr. Braun not signed on1 research report in draft

Treatment timelineeach event links to its source document

12 FEB 2026

Diagnosis

Biopsy-confirmed PDAC, head of pancreas.

Pathology_report.pdf

20 FEB 2026

Tissue resection

Whipple procedure · pancreatic head tissue.

Surgical_path.pdf

04 MAR 2026

1st-line therapy

FOLFIRINOX started · 8 cycles planned.

Treatment_history.pdf

02 JUL 2026

Progression

Hepatic mets · CA 19-9 rising trend.

Labs_CA19-9.pdf

Clinical question

Progression on first-line FOLFIRINOX after 5 months. ECOG 1. External comprehensive profiling identified a KRAS G12C alteration with intact DNA-damage-repair. The meeting will weigh candidacy for a KRAS G12C inhibitor against regional trial options, informed by the researchers' full bioinformatics analyses.

Lead's overviewcompiled from all materials

Dr. Okafor will open the meeting with a synthesized overview of the medical record, the WES/RNA-seq findings, and both research reports. Draft assembles automatically once all materials are in.

Readiness

✓

Team sign-on4 of 5 accepted

1 left

!

Files & data4 of 6 required in

2 left

•

Research reports1 of 2 submitted

1 left

The oncologists, researchers, patient, and caretakers who are part of this case.

Oncologists 2

Dr. Sana Okafor

Oncologist · Board lead

GI & pancreatic oncology

KRASImmunotherapy+6

Dr. Elias Braun

Oncologist

Melanoma & skin cancers

BRAFCheckpoint+5

Researchers 2

Priya Nair

Researcher · Bioinformatics

Single-cell & spatial genomics

scRNA-seqSpatial+5

Dr. Tomas Reyes

Researcher · Bioinformatics

Transcriptomics & pathways

RNA-seqPathway+4

Patient 1

AW

Amara Whitfield

Patient

Pancreatic adenocarcinoma · 58F

ConsentedAttends

Caretakers 1

DW

David Whitfield

Caretaker

Spouse · primary caregiver

Attends

Preparation timelineMilestones to the consortium meeting · 24 Jul (in 9 days)

06 Jul

Case opened

Done

08 Jul

Team assembled

4 of 5

by 21 Jul

Files & data

In progress

by 22 Jul

Reports submitted

1 of 2

Meeting

24 Jul · 2h

in 9 days

Members signed on · quorum requires 2 oncologists + 2 researchers

4 / 5 accepted

Dr. Sana OkaforOncologist · Lead

Accepted

Dr. Elias BraunOncologist

Invited 3d ago

Pending

Priya NairResearcher · Bioinformatics

Accepted

Dr. Tomas ReyesResearcher

Accepted

Lena FischerCoordinator

Host

Researchers on this case are enrolled on IRB protocol OMET-2026-PDAC-01 as study personnel.

Sequencing & multi-omics data · provided by researchers

Priya Nair

Whole-exome sequencing — raw RequiredFASTQ / BAM · tumor + normal

Due 21 Jul

Verified

RNA sequencing — raw RequiredFASTQ · not yet uploaded

Overdue · was 20 Jul

Missing

Multi-omics — proteomics / methylation OptionalUploaded by Dr. Reyes · 2 files

Added 12 Jul

Uploaded

Complete medical records · provided by oncologist

Dr. Okafor

Laboratory results RequiredCBC, CMP, tumor markers · CA 19-9 trend

In 08 Jul

Complete

Pathology reports RequiredBiopsy histology + IHC

In 08 Jul

Complete

Treatment history RequiredRegimens, dates, response · awaiting last cycle notes

Due 21 Jul

In progress

All filesRequiredGenomicRecordsReports

File	Category	Owner	Status	Size	Updated
WES_tumor-normal.fastq.gzRequired	Genomic · WES	P. Nair	Verified	4.2 GB	08 Jul
RNAseq_raw.fastq.gzRequired	Genomic · RNA-seq	P. Nair	Missing	—	due 20 Jul
Pathology_report.pdfRequired	Records	S. Okafor	Final	1.1 MB	08 Jul
Labs_recent-summary.pdfRequired	Records · Labs	S. Okafor	Final	640 KB	08 Jul
Treatment_history.pdfRequired	Records	S. Okafor	In progress	—	—
proteomics_methylation.zip	Genomic · optional	T. Reyes	Uploaded	820 MB	12 Jul
Nair_genomic-report.pdf	Report	P. Nair	Submitted	3.4 MB	13 Jul

Highlighted rows are the minimum-required files for the consortium — WES & RNA-seq FASTQs, pathology, recent labs, and treatment history. 1 still outstanding.

Research reportsResearch-grade bioinformatics · submitted before the meeting, reviewed by the oncologist

Genomic landscape & therapeutic implications

Priya Nair · Researcher, Bioinformatics · submitted 13 Jul

Reviewed by Dr. Okafor

Submitted

Transcriptomic profile & pathway analysis

Dr. Tomas Reyes · Researcher · draft started 11 Jul

Awaiting RNA-seq data to finalize

In draft

Priya NairResearcher2h ago

Confirmed the G12C call — VAF 31%, good coverage. My full report is submitted. Flagging that TMB is low, so IO monotherapy is unlikely to be the story here.

Care-team only

Dr. Sana OkaforLead1h ago

Reviewed, thank you Priya. We still need the RNA-seq raw so Tomas can finalize the transcriptomic report — that's our critical path to the meeting on the 24th.

Care-team only

Care-team only ▾

Personalized Multi-omics Tumor Board · Consortium

Amara Whitfield — Consortium meeting

An in-depth, up-to-two-hour molecular tumor board. The lead opens with a compiled overview, then the team works through each research report before recording a recommendation.

Incorporates research-grade bioinformatics — new insights per case

Meeting

24 July 2026

Duration

Up to 2 hours

Lead

Dr. Okafor

Format

In depth

Session outline

1

Lead overview · compiled from all materials

~15 min

2

Report — Genomic landscape · Priya Nair

~15 min

3

Report — Transcriptomic profile · Dr. Reyes

~15 min

4

Open discussion · the heart of the meeting

~60 min

5

Record recommendation

~15 min

Lead presents the compiled overview first

Attending

Dr. Sana OkaforOncologist · Lead

Dr. Elias BraunOncologist

Pending

Priya NairResearcher

Dr. Tomas ReyesResearcher

Lena FischerCoordinator

AW

Amara WhitfieldPatient · sees shared items

Documentation · inside this case

Recommendation

Draft · finalized at the meeting

OMETORIUM

Personalized Multi-omics Tumor Board · Recommendation

Amara Whitfield — Pancreatic adenocarcinoma, KRAS G12C

Meeting24 July 2026 (upcoming)Case#MTB-0142LeadDr. Sana OkaforReports2 research reports (1 pending)

Clinical question

58F, metastatic pancreatic adenocarcinoma, progression on FOLFIRINOX. KRAS G12C identified with intact DDR and low TMB. Consortium to advise on KRAS G12C–directed therapy vs. regional trial enrolment.

Draft recommendation · auto-assembled from materials, confirmed live

Pending finalization at the meeting. The lead's compiled overview and both research reports will inform the decision recorded here on 24 July.

Consensus

Vote recorded at the meeting

← Back to case

Your space

Account

Profile

Payments

Documents

Appearance

Profile

Your identity across the workspace.

Dr. Sana OkaforOncologist · Board lead · St. Martin's Oncology

Profile 80% complete — add a photo to finish.

Notifications

How Ometorium reaches you about case readiness and meetings.

Materials overdueEmail + in-app

On

Meeting reminders24h and 1h before

On

Sign out

Sign out of Ometorium on this device.

Log hours by caseYour agreed rate · $850/h

Case	Rate	Amount	Status
Amara Whitfield	$850/h	$3,400	Draft
Daniel Rösch	$850/h	$1,700	Submitted
Priyanka Bose	$850/h	$3,400	Paid

Unbilled

$5,100

Paid to date

$3,400

Project engagements+ New proposal

Whitfield — integrated multi-omics analysis

Case · Amara Whitfield · WES + RNA-seq + proteomics

$7,500

Scope_proposal_Whitfield.pdfIn progress

Ferretti — WES + RNA-seq

Case · Marco Ferretti

$6,000

Upload scope proposalProposed

Project work is billed against an agreed, uploaded scope — tracked separately from hourly time. Spatial & single-cell integration is scoped per project.

Payment method

Direct deposit (ACH)Paid straight to your US bank account.

Routing number

Account number

Direct deposit is the only payout method for now. Bank details are collected securely.

Recent payments

$3,400Priyanka Bose · 4h

Paid 15 Jul

$3,400Yuki Tanaka · 4h

Paid 2 Jul

Your agreements, tax forms, and shared paperwork for working with Ometorium.

Agreements & compliance

Document	Type	Status	Updated
Contractor_agreement.pdf	Agreement	Signed	05 Jul
W-9_tax_form.pdf	Tax	On file	05 Jul
IRB_study-personnel_letter.pdf	IRB · OMET-2026-PDAC-01	Active	08 Jul
Mutual_NDA.pdf	NDA	Signed	04 Jul

Document	Case	Amount	Status
Scope_proposal_Whitfield.pdf	Amara Whitfield	$7,500	Approved
Ferretti_scope_draft.pdf	Marco Ferretti	$6,000	Draft

Shared with you

Document	Type	From	Updated
Payment_terms.pdf	Policy	Ometorium	01 Jul
Board_member_handbook.pdf	Guide	Ometorium	01 Jul

Appearance

Ometorium follows your device's light or dark setting by default. Override it here just for your account.

Following your device setting.

← Account

Your account

Edit profile

Profile photoRequired

● Photo not added — you're using a default avatar

Add a real photo of yourself

A clear headshot helps the consortium recognize you in meetings and on the recommendations you sign. Required to complete your profile.

Identity & credentials

Full name

Title

Institution

Work email

NPI number *

ORCID iD

Identity & credentials

Full name

Title

Lab / affiliation

Work email

ORCID iD *

Researchers verify identity with ORCID — no NPI required.

Clinical focus & expertise

Focus area

Biomarker experience

KRAS / G12C ✕HER2 ✕PD-L1 ✕MSI / MMR ✕

Therapeutic areas

Targeted therapy ✕Immunotherapy ✕GI oncology ✕

Diagnostics

Comprehensive NGS panels ✕Liquid biopsy / ctDNA ✕

Bioinformatics expertise

Describe your bioinformatics expertise

Key experience

N-of-1 / single-patient multi-omicsDeep multi-omic analysis built around one patient's case.

Integrative multi-omicsCombining WES, RNA-seq, proteomics, spatial and single-cell layers.

Specialties

Single-cell RNA-seq ✕Spatial transcriptomics ✕Multi-omics integration ✕

Methods & tools

Seurat ✕Scanpy ✕

Data types

WES ✕Bulk RNA-seq ✕

About you

Preferred name

Pronouns (optional)

Tell us a little about yourself

This just helps your board know you as a person. Nothing here is required.

Short bio

Auto-import from your profiles

Paste a link to your Google Scholar, ORCID, academic, or hospital profile and we'll pull in your training, appointments, and publications for you to review.

Google ScholarORCIDAcademic pageHospital profile

Imported training, 3 appointments, and 3 publications from Google Scholar. Review below.

Training & appointments

Medical school

Residency

Fellowship

Board certification

Current appointments

None yet — add manually or use auto-import.

Publications—

No publications yet — use auto-import above to pull them from Google Scholar or ORCID, or add them manually.

Profile completeness

80%

CredentialsVerified

Expertise10 tags

ContactDone

Short bioDone

!Profile photoMissing

Your workspace

My Tasks

2

Overdue

5

Due this week

12

Completed this month

Needs attention

Upload RNA-seq raw — Amara WhitfieldRequired file · blocking the meeting

Overdue · 20 Jul

Add your profile photoProfile 80% complete

Overdue

Due this week

Confirm attendance — Amara Whitfield meeting24 Jul · up to 2 hours

Due today

Review research report — P. BoseGenomic landscape · Priya Nair

Wed

Respond to invitation — Marco FerrettiInvited by Dr. Braun

2 Aug

Oncologist · Case intake

Submit a case

Bring a patient to a Personalized Multi-omics Tumor Board. Provide the clinical picture and the question; researchers will attach sequencing once the team is assembled.

Submitting a case enrolls the patient in a research study

This is how Ometorium works with patients: the multi-omics analysis is conducted under an approved IRB protocol, and the patient must give informed consent to take part. Every researcher on the case is added to the IRB as study personnel. You'll set the protocol and the patient's consent below.

1Patient

Patient name / pseudonym

MRN

Age

Sex

2Diagnosis

Primary diagnosis

Stage / extent

Prior therapy

3Clinical question for the board

Urgency

RoutinePriorityUrgent

4Records to attachrequired set · you can add now or after submitting

Pathology reportsRequired

Recent lab testsRequired

Treatment historyRequired

WES & RNA-seq (FASTQ)Provided by the researcher once assigned

Researcher

5Propose team & meeting

Invite members

Dr. Okafor — leadDr. Braun — oncologistP. Nair — researcher+ invite

Researchers you add are enrolled on the IRB protocol as study personnel.

Target meeting date

6Research enrollment & patient consent

Ometorium works with patients by enrolling them in an IRB-approved research study — the multi-omics analysis is the research. On submit, the patient receives an invitation, verifies their email, then reviews and signs the study's informed consent. This double opt-in must be complete before the board is assembled.

IRB protocol

Patient email *

1

Verify emailPatient confirms their address & creates access.

2

Review & sign consentPatient reviews the IRB informed-consent form and enrolls in the study.

On submit, this case enters “Awaiting patient consent & enrollment” until the patient has signed the IRB consent.

Researcher · Bioinformatics

Worklist

Your action items, data uploads, and research reports across active cases.

1

Overdue

3

Due this week

8

Delivered this month

Needs attention

Respond to invitation — Marco FerrettiInvited by Dr. Braun

2 Aug

Confirm attendance — Amara Whitfield meeting24 Jul · up to 2 hours

Due today

Data to deliver

Case	Data	Due	Status
Amara Whitfield	RNA-seq raw (FASTQ)	Overdue · 20 Jul	Missing
Amara Whitfield	WES raw (FASTQ)	21 Jul	Verified
Marco Ferretti	WES raw (FASTQ)	30 Jul	Not started

Reports to submit

Case	Report	Due	Status
Amara Whitfield	Transcriptomic profile & pathways	22 Jul	In draft
Marco Ferretti	Genomic landscape	31 Jul	Not started

Administration

Admin console

Users & roles

Member	Role	Institution	Pay rate	Status
Dr. Sana Okafor	Oncologist · Lead	St. Martin's Oncology	$850/h	Active
Priya Nair	Researcher	Bioinformatics Core	Project-based · $220/h	Active
Dr. Elias Braun	Oncologist	St. Martin's Oncology	$780/h	Invited
Lena Fischer	Administrator	St. Martin's Oncology	—	Active

Pay rates are set here at onboarding, based on each member's agreement — hourly for oncologists, hourly or per-project for researchers.

Invitations

Invitee	Role	Case	Sent	Status
Dr. Elias Braun	Oncologist	Amara Whitfield	3d ago	Pending
Dr. Wei Chen	Researcher	Marco Ferretti	1d ago	Accepted
Dr. Julia Meyer	Oncologist	Amara Whitfield	4d ago	Declined

Templates · required files per case type

Solid tumor (default)This defines the minimum-required files a case must have before it can reach “Ready.”

Whole-exome sequencing — raw (FASTQ)Researcher

Required

RNA sequencing — raw (FASTQ)Researcher

Required

Pathology reportsOncologist

Required

Recent lab testsOncologist

Required

Treatment history / medical recordOncologist

Required

Proteomics / methylationResearcher

Optional

Quorum rules

Minimum oncologists

Minimum researchers

A case cannot reach “Ready” until quorum is met.

Meeting format

Default duration

Session outline: Lead overview 15m · reports 15m each · open discussion 60m · recommendation 15m.

Case teams

Case

Add or remove members from a case. The workspace stays read-only — team changes are managed here.

Dr. Sana OkaforOncologist · Board lead

Lead

Dr. Elias BraunOncologist

Priya NairResearcher

Dr. Tomas ReyesResearcher

Lena FischerCoordinator

Administration

Operations

6.4 days

Median time to ready

3

Overdue materials

5

Meetings this month

4%

No-show rate

Cases boarded per month

2

Apr

3

May

4

Jun

5

Jul

Readiness by case

Amara WhitfieldMeeting 24 Jul

Daniel RöschMeeting 18 Jul

Marco FerrettiMeeting 2 Aug

Turnaround detail

Case	Opened	Meeting	Time to ready	Overdue items	Status
Amara Whitfield	06 Jul	24 Jul	—	1	In progress
Daniel Rösch	02 Jul	18 Jul	5.1 days	0	Ready
Priyanka Bose	28 Jun	14 Jul	6.4 days	0	Concluded
Marco Ferretti	10 Jul	02 Aug	—	2	Early prep

Administration

Audit & compliance log

All eventsAccessUploadsDecisionsAdmin

Timestamp	Actor	Action	Target	Case
2026-07-15 09:42	P. Nair	Uploaded file	WES_tumor-normal.fastq.gz	Whitfield
2026-07-15 09:40	S. Okafor	Reviewed report	Nair_genomic-report.pdf	Whitfield
2026-07-14 16:20	S. Okafor	Recorded recommendation	#MTB-0138	Bose
2026-07-14 16:18	T. Reyes	Recorded dissent	#MTB-0138	Bose
2026-07-14 11:05	L. Fischer	Promoted to patient-visible	Recommendation	Bose
2026-07-13 14:31	S. Okafor	Accessed medical record	Pathology_report.pdf	Whitfield
2026-07-12 10:02	L. Fischer	Sent invitation	Dr. E. Braun · Oncologist	Whitfield
2026-07-11 08:47	L. Fischer	Changed role	W. Chen → Researcher	—

Immutable, append-only record — retained for defensibility and accreditation. Exportable as a signed report.

Your tumor board is being preparedMeeting 24 Jul

06 Jul

Case opened

Done

08 Jul

Your board

Assembled

now

Records & analysis

In progress

by 22 Jul

Expert review

Upcoming

Meeting

24 Jul

You're invited

What happens next

A team of oncologists and research scientists is preparing your case — gathering your records and running advanced multi-omics analyses of your tumor. On 24 July they meet as a board to review everything together and agree on recommendations for your care. You're invited to join the meeting by video, and your care lead will walk you through the outcome afterward. This advanced analysis is carried out as part of an IRB-approved research study you've consented to.

My task list3 to do

What your board needs from you to prepare your case.

Upload records from your previous oncologistMedical records

Due 21 Jul

Upload outside tumor sequencing, if you have itSequencing files (WES / RNA-seq) · optional

Optional

Confirm you'll attend the meeting24 Jul · by video

This week

Review the summary shared with youFrom Dr. Okafor

Done

Your documents

Drop files or click to upload — prior reports, scans, or notes you'd like your team to see

My symptom diary.pdfUploaded by you · 3 Jul

Shared with team

Plain-language case summaryShared with you by Dr. Okafor · 10 Jul

Shared with you

Your personalized molecular tumor board

Dr. Sana OkaforOncologist · Board lead

Dr. Elias BraunOncologist

Priya NairResearch scientist

Dr. Tomas ReyesResearch scientist

Lena FischerCare coordinator

Research participation

Your care is supported by a research study. The advanced analysis of your tumor is performed under an approved IRB protocol, which you consented to.

Informed consentSigned 6 Jul 2026

On file

IRB protocolOMET-2026-PDAC-01

Your meeting

24 July 2026

You're invited to attend by video · up to 2 hours

Administration

Payouts

$12,400

Pending payout

$5,100

Awaiting invoice

$18,300

Paid this month

3

Open project engagements

Member	Type	For	Amount	Method	Status
Dr. Sana Okafor	Hourly	Whitfield · 4h	$3,400	Direct deposit	Submitted
Dr. Sana Okafor	Hourly	Rösch · 2h	$1,700	Direct deposit	Draft
Priya Nair	Project	Whitfield multi-omics	$7,500	Direct deposit	In progress
Dr. Tomas Reyes	Project	Ferretti WES + RNA-seq	$6,000	—	Proposed
Dr. Elias Braun	Hourly	Tanaka · 4h	$3,400	Direct deposit	Paid 15 Jul

Approve submitted invoices to release payment. Project engagements pay against their agreed, uploaded scope.

Cases

Amara Whitfield

Oncologists 2

Researchers 2

Patient 1

Caretakers 1

Amara Whitfield — Consortium meeting

Recommendation

Clinical question

Draft recommendation · auto-assembled from materials, confirmed live

Consensus

Account

Profile

Notifications

Sign out

Appearance

Edit profile

My Tasks

Submit a case

Worklist

Admin console

Operations

Audit & compliance log

Amara Whitfield

Payouts

Amara Whitfield

Compiled molecular snapshot

Join the case team

Enter your invitation code

Identity & credentials

Your expertise

Availability & agreement

Review & join

Join your molecular tumor board

Enter your invitation code

Welcome, Amara

Your research consent

Sign to continue

Every case, met with the depth it deserves.

Welcome back

Cases

Amara Whitfield

Oncologists 2

Researchers 2

Patient 1

Caretakers 1

Amara Whitfield — Consortium meeting

Recommendation

Clinical question

Draft recommendation · auto-assembled from materials, confirmed live

Consensus

Account

Profile

Notifications

Sign out

Appearance

Edit profile

My Tasks

Submit a case

Worklist

Admin console

Operations

Audit & compliance log

Amara Whitfield

Payouts

Amara Whitfield

Compiled molecular snapshot

Join the case team

Enter your invitation code

Identity & credentials

Your expertise

Availability & agreement

Review & join

Join your molecular tumor board

Enter your invitation code

Welcome, Amara

Your research consent

Sign to continue